Citation Impact
Citing Papers
Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the World
2006 Standout
Recent advances in clinical practice: epidemiology of autoimmune liver diseases
2021
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Effect of propranolol on survival in patients with decompensated cirrhosis: a nationwide study based Danish patient registers
2016
Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production
2007 StandoutScience
ADAPT: An Algorithm Incorporating PRO‐C3 Accurately Identifies Patients With NAFLD and Advanced Fibrosis
2018
Long term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease
2014
Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension
2020
Renal and brain failure predict mortality of patients with acute-on-chronic liver failure admitted to the intensive care unit
2020
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study
2018
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Risk factors for cholangiocarcinoma
2011
Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case–control study in Italy
2001
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes
2008
Autoimmune hepatitis
2018
Risk factors for male breast cancer in Canada, 1994–1998
2002
Primary liver cancer: Worldwide incidence and trends
2004 Standout
Risk factors of intrahepatic cholangiocarcinoma in the United States: A case-control study
2005
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Marriage and health: His and hers.
2001 Standout
Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study
2011
Beta adrenergic blockade and decompensated cirrhosis
2016
Hepatocellular carcinoma
2018 Standout
Fifteen-year, single-center experience with the surgical management of intrahepatic cholangiocarcinoma: Operative results and long-term outcome
2007
Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis
2015
Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure
2015
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged
2009
Kinetic study of paracetamol on prolidase activity in erythrocytes by capillary electrophoresis with Ru(bpy)32+ electrochemiluminescence detection
2006
What we should know about portal vein thrombosis in cirrhotic patients: A changing perspective
2012
Burden of liver diseases in the world
2018 Standout
Cholangiocarcinoma
2005
Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?
2008
Carotid Artery Intima-media Thickness in Nonalcoholic Fatty Liver Disease
2008
Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: A systematic review and meta‐analysis
2009
The Coagulopathy of Chronic Liver Disease
2011
Hepatocellular carcinoma
2012 Standout
Trends in Incidence of Autoimmune Liver Diseases and Increasing Incidence of Autoimmune Hepatitis
2020
Breast cancer risk in male alcoholics in Sweden
2001
Hepatocellular carcinoma
2021 Standout
Acute-on-chronic liver failure in cirrhosis
2016
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Clinical Course of Alcoholic Liver Cirrhosis: A Danish Population-Based Cohort Study
2009
Colorectal cancer
2013 Standout
The brain and immune system prompt energy shortage in chronic inflammation and ageing
2017
Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma
2007
Mailed Outreach Program Increases Ultrasound Screening of Patients With Cirrhosis for Hepatocellular Carcinoma
2016
Contribution of Alcoholic and Nonalcoholic Fatty Liver Disease to the Burden of Liver-Related Morbidity and Mortality
2016
Omega-3 Fatty Acids Therapy in Children with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial
2015
Hepatitis B Virus Infection and Intrahepatic Cholangiocarcinoma in Korea: A Case-Control Study
2008
International Trends in Liver Cancer Incidence Rates
2011
Trends in mortality from hepatocellular carcinoma in Europe, 1980‐2004†
2008
From NAFLD in clinical practice to answers from guidelines
2013
Intensive lifestyle treatment for non-alcoholic fatty liver disease in children with severe obesity: inpatient versus ambulatory treatment
2015
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Global cancer statistics
2011 Standout
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Portal hypertensive bleeding in cirrhosis
2016 Standout
Non-alcoholic fatty liver disease
2021 Standout
Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)
2012
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
2004 Standout
Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy
2022
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
2010
Causes of Death in People with Liver Cirrhosis in England Compared with the General Population: A Population-Based Cohort Study
2015
Male breast cancer
2006 Standout
An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma From Patients With Cirrhosis
2009
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
2010
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
2003
Hypercoagulability in cirrhosis: causes and consequences
2011
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
2013
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
2010 Standout
Hemostasis and thrombosis in patients with liver disease: The ups and downs
2010
Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma
2012
Psychoactive Medications Increase the Risk of Falls and Fall-related Injuries in Hospitalized Patients With Cirrhosis
2015
Cutting edge issues in autoimmune hepatitis
2016
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Global burden of liver disease: 2023 update
2023 Standout
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
2014
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
2016
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
NASH and HCC
2009
Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease
2015
Hepatic expression and cellular distribution of the glucose transporter family
2012
Increasing Incidence and Mortality of Primary Intrahepatic Cholangiocarcinoma in the United States
2001
Prospective Evaluation of Risk Factors for Male Breast Cancer
2008
Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)
2019
Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection
2008
Statins and hepatic steatosis: Perspectives from the Dallas Heart Study
2006
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis
2016
Nonalcoholic fatty liver disease
2005 Standout
Deep Vein Thrombosis and Pulmonary Embolism in Hospitalized Patients with Cirrhosis: A Nationwide Analysis
2011
Alcohol Drinking May Increase Risk of Breast Cancer in Men: A European Population-Based Case–Control Study
2004
Extrahepatic complications of nonalcoholic fatty liver disease
2013
Cohort Study of Non-alcoholic Fatty Liver Disease, NAFLD fibrosis score, and the Risk of Incident Diabetes in a Korean population
2013
Metabolic fate of isoleucine in a rat model of hepatic encephalopathy and in cultured neural cells exposed to ammonia
2008
Clinical states of cirrhosis and competing risks
2017
Long‐term prognosis of patients with alcoholic liver cirrhosis: a 15‐year follow‐up study of 100 Norwegian patients admitted to one unit
2004
Risk Factors for Intrahepatic and Extrahepatic Cholangiocarcinoma: A Hospital-Based Case?Control Study
2007
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
2019
Hepatocellular Carcinoma
2011 Standout
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
2018
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
2005
NAFLD: A multisystem disease
2015 Standout
Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
2016
Endocrine correlates of male breast cancer risk: a case-control study in Athens, Greece
2000
Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma
2008
Helicobacter pylori as an Initiating Factor of Complications in Patients With Cirrhosis: A Single-Center Observational Study
2020
Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma
2004
Risk Factors for Male Breast Cancer—A Case-Control Study from Scandinavia
2001
Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies
2014
Hepatocellular carcinoma
2022 Standout
Increased thrombin generation in splanchnic vein thrombosis is related to the presence of liver cirrhosis and not to the thrombotic event
2014 StandoutNobel
Primary sclerosing cholangitis – a comprehensive review
2017
A Fibrosis‐Independent Hepatic Transcriptomic Signature Identifies Drivers of Disease Progression in Primary Sclerosing Cholangitis
2020 StandoutNobel
Hepatocellular Carcinoma
2019 Standout
Exosomal proteins as potential diagnostic markers in advanced non‐small cell lung carcinoma
2015
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
2016 Standout
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
2017
The Evolving Challenge of Infections in Cirrhosis
2021
Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes.
2013
Overdiagnosis: An Understudied Issue in Hepatocellular Carcinoma Surveillance
2017
Dysfunctional TCA-Cycle Metabolism in Glutamate Dehydrogenase Deficient Astrocytes
2015
L‐ornithine L‐aspartate in bouts of overt hepatic encephalopathy
2017
Glucose replaces glutamate as energy substrate to fuel glutamate uptake in glutamate dehydrogenase‐deficient astrocytes
2015
Non-alcoholic and alcoholic Fatty Liver Disease - two Diseases of Affluence associated with the Metabolic Syndrome and Type 2 Diabetes: the FIN-D2D Survey
2010
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
2017
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
2014 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Expression of the human isoform of glutamate dehydrogenase, hGDH2, augments TCA cycle capacity and oxidative metabolism of glutamate during glucose deprivation in astrocytes
2016 StandoutNobel
Increased Cancer Risk in Autoimmune Hepatitis: A Danish Nationwide Cohort Study
2021
Risk of hepatocellular carcinoma among individuals with different aetiologies of cirrhosis: a population‐based cohort study
2017
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998
2001
Understanding Nanomaterial–Liver Interactions to Facilitate the Development of Safer Nanoapplications
2022
Epidemiology and surveillance of autoimmune hepatitis in Asia
2022
Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis
2017
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Electrogenerated Chemiluminescence and Its Biorelated Applications
2008 Standout
Surveillance for hepatocellular carcinoma
2014
Cancer Risk in Patients With Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology
2021
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population
2020
Multidisciplinary Meeting on Male Breast Cancer: Summary and Research Recommendations
2010 Standout
Global cancer statistics, 2012
2015 Standout
Comorbid Chronic Diseases and Survival in Compensated and Decompensated Cirrhosis: A Population-Based Study
2022
Nonalcoholic Fatty Liver Disease
2015 Standout
Acute‐on‐chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults
2015
Management of people with early- or very early-stage hepatocellular carcinoma
2017
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
Inhibition of the oxygen sensor PHD2 in the liver improves survival in lactic acidosis by activating the Cori cycle
2015 StandoutNobel
Midodrine and tolvaptan in patients with cirrhosis and refractory or recurrent ascites: a randomised pilot study
2016
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Breast Cancer in Men
2002 Standout
Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients
2014
Works of Hendrik Vilstrup being referenced
Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites
2016
Portal vein thrombosis; risk factors, clinical presentation and treatment
2007
Nonselective β‐blockers do not affect mortality in cirrhosis patients with ascites: Post Hoc analysis of three randomized controlled trials with 1198 patients
2015
Long-term survival and cause-specific mortality in patients with cirrhosis of the liver
2003
Risk of Breast Cancer in Men With Liver Cirrhosis
1998
Acute pain induces an instant increase in natural killer cell cytotoxicity in humans and this response is abolished by local anaesthesia
1999
Incidence rates of hepatocellular carcinoma in the U.S. and Denmark: Recent trends
2007
Family occurrence of autoimmune hepatitis: A Danish nationwide registry-based cohort study
2018
Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients
2015
Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C
2014
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study Of Liver Diseases and the European Association for the Study of the Liver
2014 Standout
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2018
Cancer risk in persons receiving prescriptions for paracetamol: A Danish cohort study
2001
The nutritional management of hepatic encephalopathy in patients with cirrhosis: International society for hepatic encephalopathy and nitrogen metabolism consensus
2013
Risk of Venous Thromboembolism in Patients With Liver Disease: A Nationwide Population-Based Case–Control Study
2008
Comorbidity and survival of Danish cirrhosis patients
2008
Development and Validation of a Comorbidity Scoring System for Patients With Cirrhosis
2013
Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF)
2013
Autoimmune hepatitis in Denmark: Incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study
2013
FDG-PET Improves Management of Patients with Colorectal Liver Metastases Allocated for Local Treatment: A Consecutive Prospective Study
2007
Increased energy expenditure and glucose oxidation during acute nontraumatic skin pain in humans
2009
The metabolic role of isoleucine in detoxification of ammonia in cultured mouse neurons and astrocytes
2007
Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes
2008
Cirrhosis and mortality risks of biopsy‐verified alcoholic pure steatosis and steatohepatitis: a nationwide registry‐based study
2012
Acute Pain Induces Insulin Resistance in Humans
2001
Effect of a 10‐week Weight Loss Camp on Fatty Liver Disease and Insulin Sensitivity in Obese Danish Children
2011
Single‐centre experience of the macrophage activation marker soluble (s)CD163 – associations with disease activity and treatment response in patients with autoimmune hepatitis
2016
Extrahepatic autoimmune diseases in patients with autoimmune hepatitis and their relatives: A Danish nationwide cohort study
2018
Risk of Cancer in Patients Hospitalized With Fatty Liver
2003
Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity
2011
Liver cirrhosis, other liver diseases, and risk of hospitalisation for intracerebral haemorrhage: A Danish population-based case-control study
2008
Worldwide Incidence of Autoimmune Liver Disease
2015
Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark
1998
Prognosis of patients with liver cirrhosis and spontaneous bacterial peritonitis.
2004
The macrophage activation marker sCD 163 is associated with morphological disease stages in patients with non‐alcoholic fatty liver disease
2016
Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.
2004
Risk for Hepatocellular Carcinoma in Patients With Alcoholic Cirrhosis
2012
Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis
2016